AI assistant
AETHLON MEDICAL INC — Director's Dealing 2013
Jul 15, 2013
35398_dirs_2013-07-15_fc43b633-b15b-445e-9da4-766d171a5717.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AETHLON MEDICAL INC (AEMD)
CIK: 0000882291
Period of Report: 2013-07-09
Reporting Person: Ward Phillip A (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-07-09 | 10% Convertible Note | $0.088 | A | Acquired | 2013-10-09 | Common Stock (3465909) | Indirect |
Footnotes
F1: Unpaid principal and accrued interest on the note are convertible at Mr. Ward's option into common stock only if the note is not repaid by October 9, 2013. In that event, unpaid principal and accrued interest may be converted into common stock at $0.088/share. In addition, upon conversion of the note, Mr. Ward would receive warrants to purchase that number of shares of common stock equal to 50% of the amount of principal and interest being converted divided by $0.088, with such warrants being exercisable at a price of $0.132/share.
F2: Maturity date.